Claudio Hidalgo new CSO-CEO in Microviable Therapeutics
We are happy to welcome Claudio Hidalgo Cantabrana in our team as former CSO-CEO. […]
We are happy to welcome Claudio Hidalgo Cantabrana in our team as former CSO-CEO. […]
Responsibilities: • Design and perform experiments […]
Responsibilities: • Provide technical expertise in comparative genomics, microbiome data analysis and statistics. […]
Microviable Therapeutics and the Asturian biotechs Entrechem and Dreamgenics participate in the 25th edition of Bio Europe 2019 (Hamburg), the most important continental event in the field of life sciences and that contacts companies with [...]
Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain. […]
View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses. […]
Microviable Therapeutics, through our CEO Rafael Martínez Permuy, was part of the “Gut Microbiota for Health World Summit” (#GMFH2020) that was held on March 7 and 8 in Madrid, a great international event on microbiota [...]
El Comercio (Diario de Asturias), highlights Microviable’s activity in “the long-term isolation and storage of the microbiota under viable conditions, the analysis of its composition and, finally, the development of microbiome-based therapies. The first two business [...]
Microviable Therapeutics was in the group of technology-based companies that the CSIC presented at Transfiere 2020, the European Forum for Science, Technology and Innovation, which was held in Malaga on 12 and 13 February. During [...]
Microviable Therapeutics were at Web Summit 2019, “the best technology conference on the planet” according to Forbes. […]